# Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients

> **NCT06665880** · — · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 16 (estimated)

## Conditions studied

- Drug Resistant Epilepsy
- Traumatic Brain Injury Without Open Intracranial Wound

## Interventions

- **OTHER:** Routine clinical treatment

## Key facts

- **NCT ID:** NCT06665880
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2025-12-15
- **Final completion:** 2026-12-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06665880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06665880, "Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06665880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*